There is an urgent need to improve breast cancer patients' quality of life as available treatments have increased their lifespan, health experts said during a EURACTIV event.
The President of the European Commission launched an EU-wide public consultation on Europe's Beating Cancer Plan on Tuesday (4 February), announcing an EU-wide "open health data space" in support of research, prevention and cure.
With increased powers, Health Commissioner-designate Stella Kyriakides is tasked with striking a difficult balance between making sure there is a steady supply of affordable medicines and ensuring that EU pharma industry remains a world leader in innovation.
A group of EU lawmakers has taken the UK-led “Dying to Work” campaign to the EU in an effort to mobilise support for terminally ill patients across Europe, who face unfair treatment at work.
In view of the growing burden of metastatic breast cancer (MBC), data on recurrence of the disease is urgently needed to support further research into the specific needs of patients.
Metastatic breast cancer (MBC) has long been disregarded by advocacy groups, researchers and policymakers. As a result, little is known about the scope of the disease, its economic burden and the best way to treat it.
A group of metastatic breast cancer experts has urged policymakers to empower patients with greater choice and participation in their treatment and care, to improve the quality of life of patients, their carers and families.
Metastatic breast cancer (MBC) kills half a million women in the EU every year, yet progress on the quality of life and survival time of MBC patients remains elusive. MEPs addressed the need to improve patient outcomes with a policy roadmap launched on Tuesday (17 October).
October is breast cancer awareness month. The pink ribbon movement has achieved progress in spreading awareness and pushing for widespread cancer screening.
